Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses. (Q51965427)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 March 2008

Language	Label	Description	Also known as
English	Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses.	scientific article published on 31 March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

author name string

Adriana Baz

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Kathy Buttigieg

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Weiguang Zeng

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Michael Rizkalla

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Penny Groves

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

language of work or name

0 references

publication date

31 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

26

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

21

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

2570-2579

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

More than one reason to rethink the use of peptides in vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Toll-like receptors: linking innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Lipid-based self-adjuvanting vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Granzymes at a glance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.022

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.03.022

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18420312

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51965427&oldid=1368940766"